48,830
edits
Difference between revisions of "Fibroblastic/myofibroblastic tumours"
Jump to navigation
Jump to search
Fibroblastic/myofibroblastic tumours (view source)
Revision as of 19:26, 6 November 2013
, 19:26, 6 November 2013→Desmoid-type fibromatosis
(→Desmoid-type fibromatosis: more) |
|||
| Line 154: | Line 154: | ||
Notes: | Notes: | ||
*[[Hypertrophic scar]]-like lesion; see also ''[[dermal scar]]''. | *[[Hypertrophic scar]]-like lesion; see also ''[[dermal scar]]''. | ||
DDx: | |||
*[[Gastrointestinal stromal tumour]].<ref name=pmid23020601>{{Cite journal | last1 = Huss | first1 = S. | last2 = Nehles | first2 = J. | last3 = Binot | first3 = E. | last4 = Wardelmann | first4 = E. | last5 = Mittler | first5 = J. | last6 = Kleine | first6 = MA. | last7 = Künstlinger | first7 = H. | last8 = Hartmann | first8 = W. | last9 = Hohenberger | first9 = P. | title = β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis. | journal = Histopathology | volume = 62 | issue = 2 | pages = 294-304 | month = Jan | year = 2013 | doi = 10.1111/j.1365-2559.2012.04355.x | PMID = 23020601 }}</ref> | |||
*[[Retroperitoneal fibrosis]] - no beta-catenin staining.<ref name=pmid23020601/> | |||
====Images==== | ====Images==== | ||
| Line 167: | Line 171: | ||
===IHC=== | ===IHC=== | ||
Features:<ref name=Ref_WMSP609>{{Ref WMSP|609}}</ref> | Features:<ref name=Ref_WMSP609>{{Ref WMSP|609}}</ref> | ||
*Beta-catenin +ve - '''important'''. | *Beta-catenin +ve (nuclear<ref name=pmid23020601/>) - '''important'''. | ||
*SMA +ve ~50% of lesions. | *SMA +ve ~50% of lesions. | ||